Recipharm offers serialization for China regs; Dalton expands Toronto plant; U.S. and China fight over vitamin C

> Recipharm has launched a serialization project for a customer in China. Report

> CDMO Dalton Pharma, supported by a $2 million state grant, has expanded its sterile powder filling capabilities at its plant in Toronto, Canada. Release

> Moorfields Eye Hospital NHS Foundation Trust has decided to close its Moorfields Pharmaceuticals' central London compounding production facility, which suspended operations more than a year ago after an MHRA inspection raised some quality concerns. Release

> Dominance of Chinese makers on the vitamin C ingredient market is being challenged in U.S. court. Story